Harvard Bioscience

Update in progress

HBIO (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Instruments & Supplies

Harvard Bioscience, Inc. develops, manufactures, and markets life science technologies and services worldwide. It offers cellular and molecular tools such as infusion pumps, electroporation instruments, analyzers, spectrophotometers, and other research equipment; data acquisition and microelectrode array systems; in vitro and in vivo research platforms; preclinical telemetry, behavioral, and organ/surgical products; and respiratory and GLP-compliant data software. Brands include Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco. Based in Holliston, MA, founded 1901.

Company score

Sentiment: 0.05; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.12; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.16; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.00; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.03; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive